EUVIMEDEUVIMED entdecken
Open Access

Assessing the impact of CD73 inhibition on overcoming anti-EGFR resistance in glioma cells

Luiz Fernando Lopes Silva, Juliete Nathali Scholl, Augusto Ferreira Weber, Camila Kehl Dias, Pauline Rafaela Pizzato, VINíCIUS PIERDONá Lima, Jean Sévigny, Ana Maria Oliveira Battastini, Fabrício Figueiró

Oncology Research · 2025

DOI: 10.32604/or.2024.055508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2025. Verfasst von Luiz Fernando Lopes Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Port…. Hauptthemen laut MEDLINE: 5'-Nucleotidase, Drug Resistance, Neoplasm, Glioma, Brain Neoplasms. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

5'-NucleotidaseDrug Resistance, NeoplasmGliomaBrain NeoplasmsProtein Kinase InhibitorsHumansErbB ReceptorsCell Line, TumorCell ProliferationGPI-Linked ProteinsApoptosisCell MovementTyrphostinsQuinazolinesTumor MicroenvironmentGlioblastoma

Stichwörter der Autor:innen

CD73ChemoresistanceEpidermal growth factor receptor (EGFR)Glioblastoma (GB)Tyrphostin

Substanzen

5'-NucleotidaseErbB ReceptorsEGFR protein, humanNT5E protein, humanGPI-Linked ProteinsProtein Kinase InhibitorsTyrphostinsQuinazolines

Autor:innen und Institutionen

  • Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil.
  • Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90035-003, Brazil.
  • Département de microbiologie-infectiologie et d'immunologie, Faculté de Médecine, Université Laval, Québec City, G1V 0A6, Canada.
  • Axe maladies infectieuses et immunitaires, Centre de recherche du CHU de Québec, Université Laval, Québec City, G1V 4G2, Canada.

Zitieren

APA

Silva, L. F. L., Scholl, J. N., Weber, A. F., Dias, C. K., Pizzato, P. R., Lima, V. P., Sévigny, J., Battastini, A. M. O., & Figueiró, F. (2025). Assessing the impact of CD73 inhibition on overcoming anti-EGFR resistance in glioma cells. Oncology Research. https://doi.org/10.32604/or.2024.055508

Vancouver

Silva LFL, Scholl JN, Weber AF, Dias CK, Pizzato PR, Lima VP, et al. Assessing the impact of CD73 inhibition on overcoming anti-EGFR resistance in glioma cells. Oncology Research. 2025. doi:10.32604/or.2024.055508

BibTeX
@article{Silva2025,
  author = {Silva, Luiz Fernando Lopes and Scholl, Juliete Nathali and Weber, Augusto Ferreira and Dias, Camila Kehl and Pizzato, Pauline Rafaela and Lima, VINíCIUS PIERDONá and Sévigny, Jean and Battastini, Ana Maria Oliveira and Figueiró, Fabrício},
  title = {Assessing the impact of CD73 inhibition on overcoming anti-EGFR resistance in glioma cells},
  journal = {Oncology Research},
  year = {2025},
  doi = {10.32604/or.2024.055508}
}
Kostenlos starten →